Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Smith

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trialElizabeth Kent, Howard Sandler, James Montie, et al.
Cancer|July 23, 2003
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinomaDavid C Smith, Christopher H Chay, Rodney L Dunn, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trialKevin S Oh, Daniel E Soto, David C Smith, et al.
Journal of Visualized Experiments : Jove|May 12, 2016
Resonance Raman Spectroscopy of Extreme Nanowires and Other 1D SystemsDavid C Smith, Joseph H Spencer, Jeremy Sloan, et al.
Urology|April 3, 2003
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancerMaha Hussain, David C Smith, Basil F El-Rayes, et al.
Cancer|October 10, 2003
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinomaBeth Hellerstedt, Kenneth J Pienta, Bruce G Redman, et al.
Investigational New Drugs|August 6, 2010
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignanciesBryan J Schneider, Gregory P Kalemkerian, Deborah Bradley, et al.
Physical Chemistry Chemical Physics : PCCP|January 16, 2015
Ordered mesoporous silica films with pores oriented perpendicular to a titanium nitride substrateCalum Robertson, Richard Beanland, Stuart A Boden, et al.
The Journal of Urology|September 20, 2008
Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapyWalter J Urba, John Nemunaitis, Fray Marshall, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trialElizabeth Kent, Howard Sandler, James Montie, et al.
Cancer|July 23, 2003
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinomaDavid C Smith, Christopher H Chay, Rodney L Dunn, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trialKevin S Oh, Daniel E Soto, David C Smith, et al.
Journal of Visualized Experiments : Jove|May 12, 2016
Resonance Raman Spectroscopy of Extreme Nanowires and Other 1D SystemsDavid C Smith, Joseph H Spencer, Jeremy Sloan, et al.
Urology|April 3, 2003
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancerMaha Hussain, David C Smith, Basil F El-Rayes, et al.
Cancer|October 10, 2003
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinomaBeth Hellerstedt, Kenneth J Pienta, Bruce G Redman, et al.
Investigational New Drugs|August 6, 2010
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignanciesBryan J Schneider, Gregory P Kalemkerian, Deborah Bradley, et al.
Physical Chemistry Chemical Physics : PCCP|January 16, 2015
Ordered mesoporous silica films with pores oriented perpendicular to a titanium nitride substrateCalum Robertson, Richard Beanland, Stuart A Boden, et al.
The Journal of Urology|September 20, 2008
Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapyWalter J Urba, John Nemunaitis, Fray Marshall, et al.
Pageof 17